title: Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?
abstract: Results of recent clinical trials and experimental studies indicate that whereas atherosclerotic renovascular disease can accelerate both systemic hypertension and tissue injury in the poststenotic kidney, restoring vessel patency alone is insufficient to recover kidney function for most subjects. Kidney injury in atherosclerotic renovascular disease reflects complex interactions among vascular rarefication, oxidative stress injury, and recruitment of inflammatory cellular elements that ultimately produce fibrosis. Classic paradigms for simply restoring blood flow are shifting to implementation of therapy targeting mitochondria and cell-based functions to allow regeneration of vascular, glomerular, and tubular structures sufficient to recover, or at least stabilize, renal function. These developments offer exciting possibilities of repair and regeneration of kidney tissue that may limit progressive CKD in atherosclerotic renovascular disease and may apply to other conditions in which inflammatory injury is a major common pathway.
authors: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota stextor@mayo.edu.
authors: Stephen C
authors: SC
authors: Textor
authors: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
authors: Lilach O
authors: LO
authors: Lerman
mesh_terms: D050197:Atherosclerosis / Q000150:complications*; D006439:Hemodynamics; D006801:Humans; D007511:Ischemia / Q000209:etiology; D007668:Kidney / Q000098:blood supply / Q000473:pathology*; D008928:Mitochondria; D009393:Nephritis / Q000209:etiology / Q000473:pathology*; D018384:Oxidative Stress; D012078:Renal Artery Obstruction / Q000150:complications* / Q000503:physiopathology; D012079:Renal Circulation; D051436:Renal Insufficiency, Chronic / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*
keywords: macrophages; mesangial cells; oxidative stress; renal artery stenosis